Literature DB >> 17979702

Onconeural versus paraneoplastic antigens?

S B Eichmüller1, A V Bazhin.   

Abstract

A hallmark of naturally occurring tumor immunity is the aberrant expression of so called "onconeural antigens" or "paraneoplastic antigens". At present, these two terms are used as synonyms for proteins which are normally expressed only in neuronal tissues, but in the process of carcinogenesis, they can be detected in tumors located outside the nervous system. As neuronal tissues are immunopriveleged zones, expression of these proteins in tumor cells can induce an autoimmune response, which manifests in the generation of autoantibodies and/or specific cytotoxic T-cells. Whether or not such immune responses necessarily lead to paraneoplastic syndromes or to a beneficial antitumor response or both is not fully understood. In this review we comprehensively summarize recent literature on paraneoplastic antigens including the corresponding neurological syndromes. A unified classification is proposed with "onconeural antigens" as collective term and a number of subgroups including the recently discovered cancer-retina antigens. Certain onconeural antigens can serve as paraneoplastic antigens under conditions which have yet to be defined, implying that the paraneoplastic function is not inherent to the antigen. The potential of onconeural antigens in cancer diagnostics and treatment strategies is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979702     DOI: 10.2174/092986707782023668

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  3 in total

1.  Autoantibodies against the Ca(2+)-binding protein recoverin in blood sera of patients with various oncological diseases.

Authors:  Marina S Savchenko; Maria A Goncharskaia; Elena E Skorikova; Stefan B Eichmüller; Nikolay E Kushlinsky; Alexandr V Bazhin; Pavel P Philippov
Journal:  Oncol Lett       Date:  2011-10-31       Impact factor: 2.967

2.  The cancer-retina antigen recoverin as a potential biomarker for renal tumors.

Authors:  Marina O Golovastova; Larisa V Tsoy; Anna V Bocharnikova; Dmitry O Korolev; Olga S Gancharova; Ekaterina A Alekseeva; Ekaterina B Kuznetsova; Lyudmila V Savvateeva; Elena E Skorikova; Vladimir V Strelnikov; Vladimir A Varshavsky; Andrey Z Vinarov; Vladimir N Nikolenko; Peter V Glybochko; Evgeni Yu Zernii; Andrey A Zamyatnin; Alexandr V Bazhin; Pavel P Philippov
Journal:  Tumour Biol       Date:  2016-01-26

3.  Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.

Authors:  Tao Cui; Monica Hurtig; Graciela Elgue; Su-Chen Li; Giulia Veronesi; Ahmed Essaghir; Jean-Baptiste Demoulin; Giuseppe Pelosi; Mohammad Alimohammadi; Kjell Öberg; Valeria Giandomenico
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.